SAMSUNG PHARM (001360.KS) Earnings Analysis

SAMSUNG PHARM (001360.KS) has no confirmed upcoming earnings date. Trailing P/E -7.56.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 001360.KS next report earnings?

No confirmed upcoming earnings date is currently scheduled for 001360.KS. This page updates as the calendar is published.

001360.KS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-09-621.35 KRWn/an/an/a
2025-11-12-321 KRWn/an/an/a
2025-08-18675.44 KRWn/an/an/a
2025-05-15395.75 KRWn/an/an/a
2025-02-10-184.16237 KRWn/an/an/a
2024-11-14194.72 KRWn/an/an/a
2024-08-14-109.17929 KRWn/an/an/a

001360.KS valuation and analyst view

Trailing P/E-7.56
Trailing EPS-179.935 KRW
Price / book0.95
Dividend yield0.00%
Market cap119.53B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is SAMSUNG PHARM (001360.KS)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 001360.KS. This page updates as the calendar is published.

Did 001360.KS beat earnings last quarter?

Consensus estimate data was not available for 001360.KS's 2026-02-09 report.

What is 001360.KS's current P/E ratio and EPS?

001360.KS trades at a trailing P/E of -7.56 on trailing EPS of -179.9349985044671 KRW.

What do analysts rate 001360.KS?

001360.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.